| scholarly article | Q13442814 |
| P2093 | author name string | Hensin Tsao | |
| Durga Udayakumar | |||
| Bisundev Mahato | |||
| Michele Gabree | |||
| P2860 | cites work | Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans | Q24312946 |
| ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways | Q24321528 | ||
| Genetic association and cellular function of MC1R variant alleles in human pigmentation | Q28185942 | ||
| Genetic determinants of hair, eye and skin pigmentation in Europeans | Q28254206 | ||
| The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53 | Q28266637 | ||
| Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma | Q28270834 | ||
| Cancer statistics, 2009 | Q29547625 | ||
| A genome-wide association study identifies novel alleles associated with hair color and skin pigmentation | Q33335147 | ||
| ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma | Q33335710 | ||
| Familial atypical multiple mole-melanoma syndrome | Q33588276 | ||
| Counseling and DNA testing for individuals perceived to be genetically predisposed to melanoma: A consensus statement of the Melanoma Genetics Consortium | Q33743737 | ||
| The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2. | Q33889383 | ||
| MC1R genotype modifies risk of melanoma in families segregating CDKN2A mutations | Q34020538 | ||
| Germline p16 mutations in familial melanoma | Q34059915 | ||
| Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma | Q34086791 | ||
| Mutations associated with familial melanoma impair p16INK4 function. | Q52537796 | ||
| A mutation hotspot at the p14ARF splice site. | Q52857972 | ||
| Relationship between the debrisoquine hydroxylase polymorphism and cancer susceptibility. | Q53489724 | ||
| Increased Risk of Cancer Other Than Melanoma in CDKN2A Founder Mutation (p16-Leiden)-Positive Melanoma Families | Q56436681 | ||
| The genetics of melanoma | Q56437102 | ||
| High-risk Melanoma Susceptibility Genes and Pancreatic Cancer, Neural System Tumors, and Uveal Melanoma across GenoMEL | Q56437244 | ||
| Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group [published erratum appears in Hum Mol Genet 1998 May;7(5):941] | Q56893811 | ||
| Genotype-Phenotype Relationships in U.S. Melanoma-Prone Families With CDKN2A and CDK4 Mutations | Q57250736 | ||
| Increased Risk of Pancreatic Cancer in Melanoma-Prone Kindreds withp16INK4Mutations | Q57250780 | ||
| Germline mutation of ARF in a melanoma kindred | Q57266793 | ||
| Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus | Q57269211 | ||
| CDKN2A Variants in a Population-Based Sample of Queensland Families With Melanoma | Q57391793 | ||
| Melanocortin 1 Receptor (MC1R) Gene Variants are Associated with an Increased Risk for Cutaneous Melanoma Which is Largely Independent of Skin Type and Hair Color | Q57948627 | ||
| Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16 | Q59082348 | ||
| Origin of familial malignant melanomas from heritable melanocytic lesions. 'The B-K mole syndrome' | Q67324299 | ||
| p16 proteins from melanoma-prone families are deficient in binding to Cdk4 | Q71761332 | ||
| Vitamin D receptor polymorphisms are associated with altered prognosis in patients with malignant melanoma | Q73483258 | ||
| Novel mutations in the p16/CDKN2A binding region of the cyclin-dependent kinase-4 gene | Q74027669 | ||
| Low prevalence of germline CDKN2A and CDK4 mutations in patients with early-onset melanoma | Q74315959 | ||
| CDKN2A (P16(INK4a)) and CDK4 mutation analysis in 131 Australian melanoma probands: effect of family history and multiple primary melanomas | Q77977482 | ||
| Germline brca2 sequence variants in patients with ocular melanoma | Q77983229 | ||
| Cytochrome P450 CYP2D6 genotypes: association with hair colour, Breslow thickness and melanocyte stimulating hormone receptor alleles in patients with malignant melanoma | Q78201955 | ||
| Association of MC1R variants and risk of melanoma in melanoma-prone families with CDKN2A mutations | Q81235911 | ||
| Genetics of melanoma predisposition | Q81439784 | ||
| A germline mutation of p14/ARF in a melanoma kindred | Q84536361 | ||
| Geographical variation in the penetrance of CDKN2A mutations for melanoma | Q34134115 | ||
| Genetic testing for melanoma. | Q34158316 | ||
| Estimating CDKN2A carrier probability and personalizing cancer risk assessments in hereditary melanoma using MelaPRO. | Q34162764 | ||
| Genetics of melanoma predisposition | Q34203435 | ||
| MC1R and the response of melanocytes to ultraviolet radiation | Q34555715 | ||
| Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample | Q34561891 | ||
| Melanocortin-1 receptor structure and functional regulation. | Q34562487 | ||
| MC1R variants, melanoma and red hair color phenotype: a meta-analysis | Q34589701 | ||
| Two newly identified genetic determinants of pigmentation in Europeans | Q34779376 | ||
| Skin colour and skin cancer - MC1R, the genetic link | Q34977588 | ||
| The role of melanocortin-1 receptor polymorphism in skin cancer risk phenotypes. | Q35129937 | ||
| Cooperative effects of INK4a and ras in melanoma susceptibility in vivo | Q35195311 | ||
| Selection criteria for genetic assessment of patients with familial melanoma | Q35840024 | ||
| Management of cutaneous melanoma | Q35877006 | ||
| Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi | Q35993051 | ||
| Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2 | Q36174385 | ||
| Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors | Q36242298 | ||
| Cutaneous melanoma susceptibility and progression genes | Q36317377 | ||
| High- and low-penetrance cutaneous melanoma susceptibility genes. | Q36499211 | ||
| Malignant melanoma: genetics and therapeutics in the genomic era. | Q36567158 | ||
| Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents | Q37004819 | ||
| Malignant melanoma in the 21st century: the emerging molecular landscape | Q37211362 | ||
| Genome-wide association study identifies three loci associated with melanoma risk | Q37341178 | ||
| A polymorphism in the agouti signaling protein gene is associated with human pigmentation | Q37361476 | ||
| Common sequence variants on 20q11.22 confer melanoma susceptibility | Q37371151 | ||
| Moderate- to low-risk variant alleles of cutaneous malignancies and nevi: lessons from genome-wide association studies | Q37442888 | ||
| Melanoma genetics: an update on risk-associated genes | Q37493337 | ||
| American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility | Q37672016 | ||
| Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition | Q41335802 | ||
| Melanocortin 1 receptor variants and skin cancer risk | Q42495860 | ||
| Multiple primary melanoma revisited | Q42521143 | ||
| Novel and recurrent p14 mutations in Italian familial melanoma | Q42647994 | ||
| CDKN2A germline mutations in familial pancreatic cancer | Q44761150 | ||
| Estimating the relative risk of developing melanoma in INK4A carriers. | Q47787326 | ||
| A population-based analysis of risk factors for a second primary cutaneous melanoma among melanoma survivors. | Q52023781 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | genetic predisposition to disease | Q64843122 |
| P304 | page(s) | 190-195 | |
| P577 | publication date | 2010-09-01 | |
| P1433 | published in | Seminars in Cutaneous Medicine and Surgery | Q15761550 |
| P1476 | title | Genetic determinants of cutaneous melanoma predisposition | |
| Genetic Determinants of Cutaneous Melanoma Predisposition | |||
| P478 | volume | 29 |
| Q36843805 | Absence of germline CDKN2A mutation in Sicilian patients with familial malignant melanoma: Could it be a population-specific genetic signature? |
| Q35802430 | BRAF gene: From human cancers to developmental syndromes |
| Q28290365 | Chimeric negative regulation of p14ARF and TBX1 by a t(9;22) translocation associated with melanoma, deafness, and DNA repair deficiency |
| Q38118359 | Emerging trends in the epidemiology of melanoma |
| Q43415112 | Genetic variation at KIT locus may predispose to melanoma. |
| Q46506746 | Genome-wide DNA methylation profile of leukocytes from melanoma patients with and without CDKN2A mutations |
| Q38635393 | Germline gene polymorphisms predisposing domestic mammals to carcinogenesis |
| Q38958919 | Hormonal Regulation of the Repair of UV Photoproducts in Melanocytes by the Melanocortin Signaling Axis |
| Q56428911 | Molecular pathology of cutaneous melanoma |
| Q26750627 | Nucleotide Excision Repair and Vitamin D--Relevance for Skin Cancer Therapy |
| Q37380135 | Pharmacologic induction of epidermal melanin and protection against sunburn in a humanized mouse model |
| Q47557700 | Truncating mutations of TP53AIP1 gene predispose to cutaneous melanoma. |
| Q51189512 | Updates from the British Association of Dermatologists 91st annual meeting, 5-7 July 2011, London, U.K. |
Search more.